Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model? CNBC
- “Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering "gene therapy" treatment: cures could be bad for business in the long run.”
- “Richter cited Gilead Sciences' treatments for hepatitis C, which achieved cure rates of more than 90 percent. The company's U.S. sales for these hepatitis C treatments peaked at $12.5 billion in 2015, but have been falling ever since. Goldman estimates the U.S. sales for these treatments will be less than $4 billion this year, according to a table in the report.”
- "GILD is a case in point, where the success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients," the analyst wrote. "In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines … Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise.”
Similar to Biotech, Vitamin D is not a sustainable business model for most doctors and hospitals
- Back in 2013 a medical clinic went out of business after their patients finally got >80 ng of vitamin D
- The patients had become so healthy that their clinic visits dropped from 4 per year down to 1 per year
- That "problem" was mentioned in the 5 Minute Vitamin D video made by Vitamin D Life
- 10 reasons Why are doctors reluctant to accept vitamin D -#10 contains the quote
"It is difficult to get a man to understand something when his salary is dependent upon his not understanding it”
Upton Sinclair - I am unaware of any organization which will take an action which will result in less business, income, or profit
- Henry Lahore, founder of Vitamin D Life
However, Health Maintenance Organizations and Employers can benefit from Vitamin D
Cost savings with Vitamin D category listing has- HMOs will save millions of dollars with vitamin D HMO = Health Maintenance Organization
- With Vitamin D, HMOs will get the same income but will have significantly less outgo
- Additional HMO benefit - having healthier clients will bring in new clients (word of mouth, marketing)
- How employers can save a million dollars per 1,000 pregnancies
- Employer alliance is trying to reduce the cost of health care – Aug 2017
Hospitals would have less income as a result of vitamin D
- Hospital costs higher for those with low vitamin D (7,000 people in NE Germany) – Nov 2017
- Chance of dying in hospital cut in half by just 10 ng higher level of Vitamin D – April 2016
- Vitamin D once during pregnancy reduced infant health care costs (300 times ROI) – RCT Dec 2015
Cost savings with Vitamin D includes the following
- Medical problems are thought to be a cause of 66 percent of bankruptcies – April 2019
- Vitamin D is the 3rd most important contributor to health, following exercise and food
- 10 fewer days of ICU Mechanical Ventilation 300,000 IU injection of vitamin D – RCT March 2019
- Employers should give night shift workers free vitamin D – GMB Union June 2019
- Biology of Vitamin D – 30ng min., 50ng preferred, 1000X lower cost than health problem – Feb 2019
- Heart attack ICU costs cut in half by Vitamin D – Oct 2018
- Cost of US health exceeds the cost of food
- Curing patients is not a sustainable business model – Goldman Sachs – April 2018
- Medical insurance does not compensate for job loss by older workers who are hospitalized – Sept 2016
- If you cannot readily get medical treatment, consider Alternative Med such as vitamin D
Curing patients is not a sustainable business model – Goldman Sachs – April 2018
Printer Friendly PDF this page! Follow this page for updates
2023 visitors, last modified 16 Dec, 2019, |
This page is in the following categories (# of items in each category)